Header cover image

Hungarian (BUX) Pharma Industry Analysis

UpdatedNov 25, 2024
DataAggregated Company Financials
Companies3
  • 7D-0.2%
  • 3M-0.3%
  • 1Y24.7%
  • YTD19.6%

The Pharma industry has stayed flat over the last week. The past year has been better, since the industry has gained 25% in that time. As for the next few years, earnings are expected to grow by 14% per annum.

Industry Valuation and Performance

Has the Hungarian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 25 Nov 2024Ft2.0tFt839.6bFt212.1b7.5x9.3x2.4x
Wed, 23 Oct 2024Ft2.0tFt811.4bFt229.6b7.4x8.8x2.5x
Fri, 20 Sep 2024Ft2.0tFt811.4bFt229.3b12.5x8.7x2.5x
Sun, 18 Aug 2024Ft1.9tFt811.4bFt229.3b12.7x8.4x2.4x
Tue, 16 Jul 2024Ft1.8tFt798.9bFt188.0b11x9.7x2.3x
Thu, 13 Jun 2024Ft1.7tFt798.9bFt187.9b19.7x9.2x2.2x
Sat, 11 May 2024Ft1.8tFt805.2bFt158.9b20.2x11.3x2.2x
Mon, 08 Apr 2024Ft1.8tFt805.2bFt158.9b20.7x11.1x2.2x
Wed, 06 Mar 2024Ft1.8tFt805.2bFt158.9b21.5x11.3x2.2x
Fri, 02 Feb 2024Ft1.9tFt825.9bFt82.1b26.9x22.5x2.2x
Sun, 31 Dec 2023Ft1.7tFt825.9bFt82.1b24.8x20.2x2x
Tue, 28 Nov 2023Ft1.6tFt825.9bFt82.1b24.8x19.6x2x
Thu, 26 Oct 2023Ft1.7tFt855.2bFt110.0b20.7x15.1x1.9x
Sat, 23 Sep 2023Ft1.7tFt855.2bFt110.1b14.3x15.8x2x
Mon, 21 Aug 2023Ft1.7tFt855.2bFt110.1b14.3x15.9x2x
Wed, 19 Jul 2023Ft1.6tFt844.4bFt157.9b12.1x10.4x2x
Fri, 16 Jun 2023Ft1.6tFt844.4bFt157.9b12.9x10.1x1.9x
Sun, 14 May 2023Ft1.6tFt844.4bFt157.8b15.7x10x1.9x
Tue, 11 Apr 2023Ft1.5tFt802.8bFt155.7b14.7x9.7x1.9x
Thu, 09 Mar 2023Ft1.4tFt755.1bFt242.6b12.8x5.9x1.9x
Sat, 04 Feb 2023Ft1.5tFt755.1bFt242.6b14x6.3x2x
Mon, 02 Jan 2023Ft1.6tFt755.1bFt242.5b6.4x6.5x2.1x
Wed, 30 Nov 2022Ft1.6tFt755.1bFt242.5b6.5x6.6x2.1x
Fri, 28 Oct 2022Ft1.5tFt694.8bFt198.3b7.7x7.8x2.2x
Sun, 25 Sep 2022Ft1.4tFt694.8bFt198.3b6.9x6.9x2x
Tue, 23 Aug 2022Ft1.5tFt694.8bFt198.3b7.5x7.5x2.1x
Thu, 21 Jul 2022Ft1.5tFt657.8bFt149.8b10.1x10.1x2.3x
Sat, 18 Jun 2022Ft1.3tFt657.8bFt149.8b8.5x8.5x1.9x
Mon, 16 May 2022Ft1.3tFt630.6bFt139.6b9x9x2x
Wed, 13 Apr 2022Ft1.3tFt630.6bFt139.6b9.3x9.3x2.1x
Fri, 11 Mar 2022Ft1.3tFt630.6bFt139.6b9.4x9.5x2.1x
Sun, 06 Feb 2022Ft1.5tFt604.7bFt114.7b13.2x13.2x2.5x
Tue, 04 Jan 2022Ft1.7tFt604.7bFt114.7b14.4x14.4x2.7x
Thu, 02 Dec 2021Ft1.6tFt604.7bFt114.7b14x14x2.7x
Price to Earnings Ratio

14x


Total Market Cap: Ft1.6tTotal Earnings: Ft114.7bTotal Revenue: Ft604.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Hungarian Pharma Industry Price to Earnings3Y Average 11.1x202220232024
Current Industry PE
    There are only 3 companies in the Hungarian Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 23% per year over the last three years.
  • Revenues for these companies have grown 12% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Hungarian Healthcare industry?

HU Market1.97%
Healthcare-0.20%
Pharma-0.20%
Pharma-0.20%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.